Effects of botulinum toxin type A for spastic foot in post-stroke patients enrolled in a rehabilitation program

The objective of this study was to evaluate the effects of botulinum toxin type A (BTX-A) on spastic foot in stroke patients in a rehabilitation program. Method: Hemiparetic stroke patients (n=21) enrolled in a rehabilitation program were divided into two groups. The first group (n=11) received a total of 300UI BTX-A, and the second group (n=10) received 100 UI BTX-A. All patients were assessed at baseline and 2, 4, 8 and 12 weeks after injection for Modified Ashworth Score, time walking 10 meters, and the Functional Independence Measure (mFIM) motor score. Results: The higher-dose group exhibited a significant improvement in spasticity, and both groups showed an improvement in time walking 10 meters and mFIM, with no significant differences between them. Conclusions: Our findings suggest that gains in gait velocity and functional independence were not correlated to BTX-A dose.

Saved in:
Bibliographic Details
Main Authors: Pimentel,Leonardo Halley Carvalho, Alencar,Francisco José, Rodrigues,Leonardo Raphael Santos, Sousa,Francisca Cléa Florenço de, Teles,João Batista Mendes
Format: Digital revista
Language:English
Published: Academia Brasileira de Neurologia - ABNEURO 2014
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2014000100028
Tags: Add Tag
No Tags, Be the first to tag this record!